These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Pearlman DM; Najjar S Schizophr Res; 2014 Aug; 157(1-3):249-58. PubMed ID: 24882425 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis. Pollak TA; McCormack R; Peakman M; Nicholson TR; David AS Psychol Med; 2014 Sep; 44(12):2475-87. PubMed ID: 24330811 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of N-Methyl-d-Aspartate Receptor antibody (NMDAR-Ab) encephalitis in patients with first episode psychosis and treatment resistant schizophrenia on clozapine, a population based study. Kelleher E; McNamara P; Dunne J; Fitzmaurice B; Heron EA; Whitty P; Walsh R; Mooney C; Hogan D; Conlon N; Gill M; Vincent A; Doherty CP; Corvin A Schizophr Res; 2020 Aug; 222():455-461. PubMed ID: 32499165 [TBL] [Abstract][Full Text] [Related]
13. Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis. Deakin J; Lennox BR; Zandi MS Biol Psychiatry; 2014 Feb; 75(4):284-91. PubMed ID: 23988024 [TBL] [Abstract][Full Text] [Related]